Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate
Product Images NDC 68462-376

10 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate (NDC 68462-376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eestructure.jpg (Image 01)

Eestructure.jpg (Image 01)
Chemical structure of ethinyl estradiol, one of the active ingredients in norethindrone acetate and ethinyl estradiol and ferrous fumarate by Glenmark Pharmaceuticals Inc.*
FDA Label Image

Nestructure.jpg (Image 02)

Nestructure.jpg (Image 02)
Chemical structure of norethindrone acetate, one of the active ingredients in the combination tablet norethindrone acetate and ethinyl estradiol with ferrous fumarate by Glenmark Pharmaceuticals Inc.*
FDA Label Image

Fig1.jpg (Image 03)

Fig1.jpg (Image 03)
A line graph showing norethindrone concentration (pg/mL) over time (hours). The y-axis represents norethindrone concentration, ranging from 0 to 14,000 pg/mL, and the x-axis represents time from 0 to 36 hours. The graph depicts a peak concentration shortly after time zero, followed by a gradual decrease over 36 hours with error bars indicating variability at each time point.*
FDA Label Image

Fig2.jpg (Image 04)

Fig2.jpg (Image 04)
A line graph depicting ethinyl estradiol concentration (pg/mL) over time (hours). The graph shows data points with error bars indicating variability, with concentrations peaking early and gradually declining over a 36-hour period.*
FDA Label Image

Pregnancychart.jpg (Image 05)

Pregnancychart.jpg (Image 05)
A vertical chart showing pregnancy rates per 100 women in one year correlated with types of birth control methods. The top indicates fewer than 1 pregnancy with methods like implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones. Mid-level pregnancy rates of 10 to 20 include condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal. At the bottom, 85 or more pregnancies occur with no birth control use.*
FDA Label Image

Blister.jpg (Image 06)

Blister.jpg (Image 06)
Blister card label for norethindrone acetate and ethinyl estradiol and ferrous fumarate tablets USP, 1 mg/20 mcg strength. The label indicates a 28-tablet pack for oral use, organized by day and week, manufactured by Glenmark Pharmaceuticals Inc., USA. The card includes a tracking system for daily dosing.*
FDA Label Image

Carton.jpg (Image 07)

Carton.jpg (Image 07)
Packaging label for norethindrone acetate and ethinyl estradiol and ferrous fumarate tablets USP by Glenmark Pharmaceuticals Inc., USA. Each white tablet contains 1 mg norethindrone acetate and 20 mcg ethinyl estradiol, and each brown tablet contains 75 mg ferrous fumarate. The label mentions mint flavor for white tablets and includes dosage, storage information, and package contents: 3 pouches each with one blister card of 28 tablets.*
FDA Label Image

Blister.jpg (Image 08)

Blister.jpg (Image 08)
Blister card packaging label for norethindrone acetate and ethinyl estradiol and ferrous fumarate tablets USP, 1 mg/20 mcg strength, containing 28 tablets. The label includes a 4-week daily pill layout with days of the week marked, produced by Glenmark Pharmaceuticals Inc., USA. The packaging specifies the combined oral contraceptive composition and has spaces for lot and expiration information.*
FDA Label Image

Logo.jpg (Image 09)

FDA Label Image

Laminate.jpg (Image 10)

Laminate.jpg (Image 10)
Packaging label for Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets USP, 1 mg/20 mcg, white mint-flavored tablets in a blister card of 28 tablets. The label includes directions about tablet colors, dosing instructions, storage conditions, manufacturer Glenmark Pharmaceuticals Inc., and NDC 68462-376-84.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.